Skip to main content

Vistagen Therapeutics, Inc.

VTGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001411685

No open-market purchases or sales by Vistagen Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $2.54M in total; no superinvestor holds it.

13F holders, Q4 2023

Institutional positions in Vistagen Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
46
+12 vs. Q3 2023
Shares held
17.6M
+14.6M (+485.5%) vs. Q3 2023
Total value
$90.0M
+$74.2M (+471.7%) vs. Q3 2023
New holders
24
15 more added
Sold out
12
2 more reduced

Compare with Q3 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VTGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2023: 46 institutions
Q1 2021: 74 institutionsQ2 2021: 101 institutionsQ3 2021: 105 institutionsQ4 2021: 106 institutionsQ1 2022: 116 institutionsQ2 2022: 112 institutionsQ3 2022: 93 institutionsQ4 2022: 86 institutionsQ1 2023: 83 institutionsQ2 2023: 33 institutionsQ3 2023: 34 institutionsQ4 2023: 46 institutionsQ1 2024: 42 institutionsQ2 2024: 43 institutionsQ3 2024: 47 institutionsQ4 2024: 54 institutionsQ1 2025: 48 institutionsQ2 2025: 51 institutionsQ3 2025: 58 institutionsQ4 2025: 55 institutionsQ1 2026: 56 institutionsQ2 2026: 48 institutions
Value heldQ4 2023: $90.0M
Q1 2021: $225.2MQ2 2021: $389.0MQ3 2021: $360.2MQ4 2021: $269.2MQ1 2022: $167.8MQ2 2022: $122.1MQ3 2022: $9.13MQ4 2022: $4.15MQ1 2023: $4.79MQ2 2023: $1.82MQ3 2023: $15.7MQ4 2023: $90.0MQ1 2024: $90.8MQ2 2024: $56.3MQ3 2024: $45.3MQ4 2024: $44.9MQ1 2025: $39.0MQ2 2025: $30.3MQ3 2025: $81.8MQ4 2025: $8.84MQ1 2026: $8.12MQ2 2026: $2.54M
Institutions holding VTGN and their total value by quarter
QuarterHoldersValue
Q2 202648$2.54M
Q1 202656$8.12M
Q4 202555$8.84M
Q3 202558$81.8M
Q2 202551$30.3M
Q1 202548$39.0M
Q4 202454$44.9M
Q3 202447$45.3M
Q2 202443$56.3M
Q1 202442$90.8M
Q4 202346$90.0M
Q3 202334$15.7M
Q2 202333$1.82M
Q1 202383$4.79M
Q4 202286$4.15M
Q3 202293$9.13M
Q2 2022112$122.1M
Q1 2022116$167.8M
Q4 2021106$269.2M
Q3 2021105$360.2M
Q2 2021101$389.0M
Q1 202174$225.2M

Institutions, Q4 2023

Shares, value and share of portfolio for each institution holding Vistagen Therapeutics, Inc.; share changes are against Q3 2023.

Institutions holding VTGN in Q4 2023
InstitutionSharesValue% of portfolioChange in sharesAction
TCG Crossover Management, LLC2,676,580$13.8M1.53%+2,676,580New
BVF Inc2,000,000$10.3M0.26%+2,000,000New
Great Point Partners LLC1,858,735$9.55M1.63%+1,858,735New
Vanguard Group Inc1,834,512$9.43M0.00%+1,580,797+623.1%Added
Nantahala Capital Management, LLC1,816,730$9.34M0.93%+1,816,730New
StemPoint Capital LP1,790,182$8.76M2.36%+1,790,182New
Commodore Capital LP1,575,000$8.10M0.71%00.0%Unchanged
Sphera Funds Management Ltd.808,550$4.16M0.77%+708,550+708.6%Added
Citadel Advisors LLC743,495$3.82M0.00%+734,943+8,593.8%Added
Armistice Capital, LLC478,000$2.46M0.07%+478,000New
BlackRock Inc.346,683$1.78M0.00%+258,637+293.8%Added
Geode Capital Management, LLC274,472$1.41M0.00%+201,308+275.1%Added
ADAR1 Capital Management, LLC245,502$1.26M0.56%+245,502New
Two Sigma Investments, LP192,059$987.2K0.00%+192,059New
Goldman Sachs Group Inc163,788$841.9K0.00%+163,788New
BML Capital Management, LLC150,000$771.0K0.61%+50,000+50.0%Added
Bank of Montreal96,900$524.2K0.00%+96,900New
Blair William & Co88,046$452.6K0.00%+2,873+3.4%Added
Citigroup Inc58,377$300.1K0.00%+58,336+142,282.9%Added
AdvisorShares Investments LLC54,311$279.2K0.07%+54,311New
State Street Corp49,508$254.5K0.00%+24,044+94.4%Added
Northern Trust Corp48,839$251.0K0.00%+34,315+236.3%Added
DAFNA Capital Management LLC41,886$215.3K0.05%+41,886New
Charles Schwab Investment Management Inc23,302$119.8K0.00%+23,302New
Barclays PLC23,077$118.6K0.00%+23,077New
Jane Street Group, LLC21,940$112.8K0.00%+21,940New
Morgan Stanley19,574$100.6K0.00%+17,014+664.6%Added
Bank of America Corp19,399$99.7K0.00%+18,766+2,964.6%Added
Virtu Financial LLC15,524$80.0K0.01%+15,524New
Bank of New York Mellon Corp15,171$78.0K0.00%+15,171New
Simplex Trading, LLC12,371$63.0K0.00%+9,907+402.1%Added
Advisor Group Holdings, Inc.10,466$53.8K0.00%+5,653+117.5%Added
Janney Montgomery Scott LLC10,000$51.0K0.00%+10,000New
Tower Research Capital LLC (TRC)9,298$47.8K0.00%+9,298New
GPS Wealth Strategies Group, LLC8,441$43.4K0.01%00.0%Unchanged
CWM, LLC2,449$13.0K0.00%00.0%Unchanged
Royal Bank of Canada1,437$7.00K0.00%−1,423−49.8%Reduced
BFSG, LLC1,000$5.14K0.00%+1,000New
First Manhattan Co333$1.71K0.00%+333New
Wells Fargo & Company208$1.07K0.00%+140+205.9%Added
Cutler Group LP200$1.00K0.00%+200New
UBS Group AG117$6010.00%−1,381−92.2%Reduced
EverSource Wealth Advisors, LLC88$4520.00%00.0%Unchanged
Jones Financial Companies LLLP80$4110.00%+80New
Fairman Group, LLC29$1490.00%+29New
JPMorgan Chase & Co16$820.00%00.0%Unchanged
Ikarian Capital, LLC0$00.00%−229,100−100.0%Sold out
Schonfeld Strategic Advisors LLC0$00.00%−138,500−100.0%Sold out
Group One Trading, L.P.0$00.00%−75,305−100.0%Sold out
MYDA Advisors LLC0$00.00%−50,000−100.0%Sold out
Boothbay Fund Management, LLC0$00.00%−46,895−100.0%Sold out
Gsa Capital Partners LLP0$00.00%−46,782−100.0%Sold out
Prelude Capital Management, LLC0$00.00%−20,200−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−19,355−100.0%Sold out
Millennium Management LLC0$00.00%−16,870−100.0%Sold out
Raymond James & Associates0$00.00%−10,000−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−1,192−100.0%Sold out
Toronto Dominion Bank0$00.00%−46−100.0%Sold out